Related Experiment Videos

Traumatic brain injury: developmental differences in glutamate receptor response and the impact on treatment

P M Lea1, A I Faden

  • 1Department of Neuroscience, Georgetown University Medical Center, Washington, DC, USA.

Insights

Perinatal brain injury can cause lifelong pediatric disabilities. Glutamate receptors play a key role in neuronal cell death, influencing treatment strategies for brain injury in developing infants.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Pediatric Neurology

Background:

  • Perinatal brain injury from trauma, hypoxia, or ischemia is a major cause of pediatric disabilities.
  • Neuronal cell death occurs via necrosis or apoptosis following such injuries.
  • Glutamate receptors, including ionotropic (iGluRs) and metabotropic (mGluRs), are implicated in modulating this cell death.

Purpose of the Study:

  • To investigate the role of glutamate receptors in perinatal brain injury.
  • To understand how developmental age influences glutamate receptor expression and function post-injury.
  • To explore potential therapeutic targets for pediatric brain injury.

Main Methods:

  • In vivo and in vitro studies examining neuronal cell death mechanisms.
  • Analysis of glutamate receptor expression patterns across developmental stages.
  • Investigation of the effects of N-methyl-D-aspartate receptor antagonists and group I mGluRs on cell death.

Main Results:

  • Glutamate receptor expression varies with developmental age, impacting injury outcomes.
  • The developing brain shows increased susceptibility to apoptosis post-injury.
  • Caspase-mediated cell death may be worsened by N-methyl-D-aspartate receptor antagonists.
  • Group I metabotropic glutamate receptors exhibit differential effects on necrotic versus apoptotic cell death.

Conclusions:

  • Understanding developmental changes in glutamate receptor function is crucial for treating perinatal brain injury.
  • Targeting specific glutamate receptor pathways may offer novel therapeutic avenues.
  • Differential modulation of necrosis and apoptosis by glutamate receptors presents complex treatment considerations.

Related Concept Videos